Bio-Techne Corp (TECH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 12-2004 | 09-2004 | 06-2004 | 03-2004 | 12-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 69,626 | 62,240 | 51,201 | 51,726 | 47,972 |
| Marketable Securities | 47,104 | 44,276 | 42,534 | 111,871 | 102,347 |
| Receivables | 19,745 | 19,654 | 21,099 | 22,548 | 18,780 |
| Inventories | 8,079 | 7,874 | 7,457 | 7,295 | 7,144 |
| Income taxes - deferred | 5,035 | 4,926 | 4,820 | 4,643 | 4,531 |
| TOTAL | $150,571 | $139,959 | $128,065 | $199,308 | $181,894 |
| Non-Current Assets | |||||
| PPE Net | 79,119 | 79,753 | 80,504 | 81,354 | 81,707 |
| Investments And Advances | 105,353 | 97,956 | 91,342 | 0 | 0 |
| Intangibles | 14,748 | 15,054 | 15,359 | 15,759 | 16,159 |
| Other Non-Current Assets | 9,696 | 9,899 | 10,190 | 16,182 | 14,021 |
| TOTAL | $208,916 | $202,662 | $197,395 | $113,295 | $111,887 |
| Total Assets | $359,487 | $342,621 | $325,460 | $312,603 | $293,781 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,271 | 1,299 | 1,281 | 1,268 | 1,259 |
| Accounts payable and accrued liabilities | 4,614 | 6,263 | 3,847 | 4,544 | 5,260 |
| Accrued Expenses | 2,923 | 2,911 | 3,416 | 3,220 | 1,981 |
| TOTAL | $13,214 | $15,433 | $13,459 | $14,300 | $12,572 |
| Non-Current Liabilities | |||||
| Long Term Debt | 13,958 | 14,244 | 14,576 | 14,900 | 15,219 |
| TOTAL | $13,958 | $14,244 | $14,576 | $14,900 | $15,219 |
| Total Liabilities | $27,172 | $29,677 | $28,035 | $29,200 | $27,791 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 165,277 | 165,255 | 164,676 | 164,400 | 164,315 |
| Common Shares | 413 | 412 | 412 | 411 | 410 |
| Retained earnings | 251,809 | 236,875 | 222,728 | 209,362 | 194,751 |
| Other shareholders' equity | 8,149 | 5,432 | 5,325 | 6,298 | 5,346 |
| TOTAL | $332,315 | $312,944 | $297,425 | $283,403 | $265,990 |
| Total Liabilities And Equity | $359,487 | $342,621 | $325,460 | $312,603 | $293,781 |